Cytosorbents CorporationCTSONASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank57
3Y CAGR+15.4%
5Y CAGR-34.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+15.4%/yr
vs -36.2%/yr prior
5Y CAGR
-34.3%/yr
Recent acceleration
Acceleration
+51.6pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 4.46 | +109.4% |
| 2023 | 2.13 | +11.5% |
| 2022 | 1.91 | -34.2% |
| 2021 | 2.90 | -25.7% |
| 2020 | 3.91 | -89.3% |
| 2019 | 36.33 | +147.9% |
| 2018 | 14.66 | -16.2% |
| 2017 | 17.49 | +106.0% |
| 2016 | -292.38 | -1831.9% |
| 2015 | 16.88 | - |